hotspot -WSS

hotspot

author：fashion 2025-09-06 03:25:53 - browse：8841

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： As Taiwan prepares for anti

explore

WSS

Providers still hesitate to prescribe buprenorphine, study finds

CDC backtracks, saying fully vaccinated people can go maskless indoors

In new study, freeze

Cano Health’s bankruptcy is a warning for Medicare Advantage

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

7 of the most gruesome medical devices in history

explore

hotspot

Gilead needs Arcellx more than ever

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

AbbVie dramatically boosts its spending on lobbying

Jerome Adams on the need for new antivirals for Covid

Review: 'Barbie' will hit you like a shot in the heart

Peter Hotez and the public health issue of online harassment

Unique patient identifier: Experts argue the benefits, pitfalls

Hepatitis C has a cure — but many Americans still lack access to it

CDC backtracks, saying fully vaccinated people can go maskless indoors

BioMarin wins approval for gene therapy to treat hemophilia A

The Biogen Aduhelm mess could happen again

Wikipedia

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Why an extreme heat and wildfire smoke combination can be so dangerous

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Elizabeth Warren probes abortion access

Marvel Studios reveals new trailer for 'The Marvels': Watch here

explore

hotspot

focus

hotspot